[Federal Register Volume 77, Number 53 (Monday, March 19, 2012)]
[Notices]
[Pages 16043-16044]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-6567]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Public Hearing

SUMMARY: The National Institutes of Health (NIH) will hold a public 
meeting on Thursday, April 19, 2012, from 6:30-9:30 p.m. at Roxbury 
Community College, Main Stage, 1234 Columbus Avenue, Boston, MA 02120. 
The

[[Page 16044]]

purpose of the meeting is to solicit public comments regarding the 
Draft Supplementary Risk Assessment for the National Emerging 
Infectious Diseases Laboratories. Comments provided during the meeting, 
as well as those received during the public comment period, will be 
considered in NIH's preparation of the Final Supplementary Risk 
Assessment for the National Emerging Infectious Diseases Laboratories. 
Individuals wishing to provide oral comments at the meeting must sign-
in prior to the start of the meeting. Sign-in will begin at 5:30 p.m. 
In order to ensure everyone has the opportunity to speak, comments must 
be limited to no longer than three minutes. An agenda, slides for the 
meeting, and the draft supplementary risk assessment will be available 
at: http://nihblueribbonpanel-bumc-neidl.od.nih.gov/meetings.asp. This 
public meeting is part of the 67-day public comment period initiated 
with the publication of a Notice of Availability in the Federal 
Register on February 24, 2012. The 67-day comment period began on 
February 24, 2012 and will end on May 1, 2012. Written comments can 
also be sent to: National Institutes of Health, ATTN: NEIDL Risk 
Assessment, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, or 
emailed to [email protected].
    For further information concerning this meeting, please contact 
Office of Biotechnology Activities, National Institutes of Health, 6705 
Rockledge Drive, Suite 750, Bethesda, MD 20892; telephone: 301-496-
9838; email: [email protected]. Requests for reasonable 
accommodations or translation services should be made to [email protected] no later than April 12, 2012.

    Dated: March 7, 2012.
Kelly Fennington,
Senior Health Policy Analyst, Office of Science Policy, National 
Institutes of Health.
[FR Doc. 2012-6567 Filed 3-16-12; 8:45 am]
BILLING CODE 4140-01-P